drugset / Trial / NCT06444243
Psilocybin-assisted Therapy for Alcohol Use Disorder
RandomizedParallel-groupDouble-blindOther
Summary
To explore the effectiveness of psilocybin-assisted therapy on reducing alcohol consumption in a double-blind, randomised, phase II clinical trial.
Timeline
- Start
- 2024-09
- Primary completion
- 2025-07
- Completion
- 2025-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Niacin | Small molecule | 250 mg | — |
| Subject | Psilocybin | Other / unclassified | 25 mg | — |